Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intensive Induction for Newly Diagnosed Acute Myelogenous Leukemia

NCT00274807 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT00274807
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00274807 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intensive Induction for Newly Diagnosed Acute Myelogenous Leukemia
Lead sponsor
The Cleveland Clinic
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2001
Completion date
May 31, 2008
Enrollment
40 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia